tiprankstipranks
Advertisement
Advertisement
Caris Life Sciences price target lowered to $34 from $38 at Evercore ISI
PremiumThe FlyCaris Life Sciences price target lowered to $34 from $38 at Evercore ISI
1M ago
Caris Life Sciences price target lowered to $38 from $45 at BTIG
Premium
The Fly
Caris Life Sciences price target lowered to $38 from $45 at BTIG
1M ago
Caris Life Sciences price target raised to $28 from $26 at Baird
Premium
The Fly
Caris Life Sciences price target raised to $28 from $26 at Baird
1M ago
Caris Life Sciences initiated with an Outperform at Baird
PremiumThe FlyCaris Life Sciences initiated with an Outperform at Baird
1M ago
Caris Life Sciences sees Q4 revenue $281M, consensus $204.31M
Premium
The Fly
Caris Life Sciences sees Q4 revenue $281M, consensus $204.31M
3M ago
Caris Life Sciences sees FY25 revenue $800M, consensus $723.42M
Premium
The Fly
Caris Life Sciences sees FY25 revenue $800M, consensus $723.42M
3M ago
Caris Life Sciences partners with Roche’s Genentechh for cancer targets
PremiumThe FlyCaris Life Sciences partners with Roche’s Genentechh for cancer targets
3M ago
Caris Life Sciences price target lowered to $35 from $39 at BofA
Premium
The Fly
Caris Life Sciences price target lowered to $35 from $39 at BofA
4M ago
Caris Life Sciences initiated with a Hold at Canaccord
Premium
The Fly
Caris Life Sciences initiated with a Hold at Canaccord
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100